Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia

Steven W. Paugh, Barbara S. Paugh, Mohamed Rahmani, Dmitri Kapitonov, Jorge A. Almenara, Tomasz Kordula, Sheldon Milstien, Jeffrey K. Adams, Robert E. Zipkin, Steven Grant, Sarah Spiegel

Blood (2008) 112 (4): 1382–1391.

https://doi.org/10.1182/blood-2008-02-138958

Published: 2008

Journal Articles

Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions

Carole A. Oskeritzian, Sergio E. Alvarez, Nitai C. Hait, Megan M. Price, Sheldon Milstien, Sarah Spiegel

Blood (2008) 111 (8): 4193–4200.

https://doi.org/10.1182/blood-2007-09-115451

Published: 2008

Journal Articles

The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors

Shawn G. Payne, Carole A. Oskeritzian, Rachael Griffiths, Preeti Subramanian, Suzanne E. Barbour, Charles E. Chalfant, Sheldon Milstien, Sarah Spiegel

Blood (2006) 109 (3): 1077–1085.

https://doi.org/10.1182/blood-2006-03-011437

Published: 2006

Journal Articles

Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors

Puneet S. Jolly, Meryem Bektas, Kenneth R. Watterson, Heidi Sankala, Shawn G. Payne, Sheldon Milstien, Sarah Spiegel

Blood (2005) 105 (12): 4736–4742.

https://doi.org/10.1182/blood-2004-12-4686

Published: 2005

Journal Articles

Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6

James R. Van Brocklyn, Markus H. Gräler, Günter Bernhardt, John P. Hobson, Martin Lipp, Sarah Spiegel

Blood (2000) 95 (8): 2624–2629.

https://doi.org/10.1182/blood.V95.8.2624

Published: 2000

Journal Articles

Liposomal ET-18-OCH 3 Induces Cytochrome c -Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling

Olivier Cuvillier, Eric Mayhew, Andrew S. Janoff, Sarah Spiegel

Blood (1999) 94 (10): 3583–3592.

https://doi.org/10.1182/blood.V94.10.3583.422k31_3583_3592

Published: 1999

NARROW

A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia

Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions

The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors

Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors

Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6

Liposomal ET-18-OCH 3 Induces Cytochrome c -Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling

Email alerts

ASH Publications

American Society of Hematology

A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia

Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions

The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors

Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors

Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6

Liposomal ET-18-OCH 3 Induces Cytochrome c -Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only